Yardley, PA, United States of America

Russell Gould

This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Johnson & Johnson Consumer Inc., Kenvue Brands LLC, Cornell University. Active years: 2020-2026.

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.9

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Russell Gould: Innovator in Allergy Treatment

Introduction

Russell Gould is an accomplished inventor based in Yardley, PA (US). He has made significant contributions to the field of allergy treatment, holding a total of 5 patents. His innovative approaches focus on addressing childhood atopic diseases and personalizing allergy symptom management.

Latest Patents

One of his latest patents is a "Combination method for treating or preventing childhood atopic disease." This application describes methods aimed at treating or reducing the onset of childhood atopic diseases through an integrated solution that considers the temporal and sequential administration of three specific approaches for optimal effectiveness. Another notable patent is the "Method to mitigate allergen symptoms in a personalized and hyperlocal manner." This system and method determine an individual's allergy impact profile, predicting how environmental conditions may affect their allergy symptoms and recommending appropriate treatments.

Career Highlights

Russell Gould has worked with prominent organizations, including Johnson & Johnson Consumer Inc. and Cornell University. His experience in these institutions has allowed him to develop and refine his innovative methods for allergy treatment.

Collaborations

Some of his notable coworkers include Russel M Walters and Matthew Richtymyer, who have contributed to his research and development efforts.

Conclusion

Russell Gould's work in allergy treatment showcases his dedication to improving the lives of individuals affected by atopic diseases. His innovative patents reflect a commitment to advancing medical solutions in this critical area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…